Skip to main content
Jinyu Bio-Technology Co.,Ltd. logo

Jinyu Bio-Technology Co.,Ltd. — Investor Relations & Filings

Ticker · 600201 ISIN · CNE000000Y37 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,777 across all filing types
Latest filing 2016-09-21 Capital/Financing Update
Country CN China
Listing Shanghai Stock Exchange 600201

About Jinyu Bio-Technology Co.,Ltd.

http://jinyubiotech.com/

Jinyu Bio-Technology Co., Ltd. focuses on the research, development, and manufacturing of veterinary biological products and pharmaceuticals. The company is a prominent supplier of animal vaccines, particularly specializing in Foot-and-Mouth Disease (FMD) vaccines, brucellosis vaccines, and solutions for swine and poultry diseases. It utilizes advanced biotechnology platforms, including large-scale suspension culture and high-efficiency purification processes, to produce high-titer, high-purity biologicals. The organization operates sophisticated research facilities and Biosafety Level 3 (P3) laboratories to support the development of diagnostic reagents and preventive treatments. Its operations center on enhancing animal health through scientific innovation, providing comprehensive disease control strategies for the global livestock industry and large-scale agricultural operations.

Recent filings

Filing Released Lang Actions
北京市中伦律师事务所关于金宇生物技术股份有限公司非公开发行股票发行过程和认购对象合规性的法律意见书
Capital/Financing Update Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the compliance of a company's non-public stock issuance process and subscription targets. It includes detailed descriptions of board and shareholder approvals, subscription invitations, pricing, allocation, and capital verification reports. The content focuses on the legal and procedural aspects of a capital raising event (non-public stock issuance). It is not a financial report, earnings release, or management discussion. It is a legal opinion related to capital issuance, which aligns with the category of Capital/Financing Update (CAP). The document is substantive and detailed, not a brief announcement or certification, so it is not Regulatory Filings (RNS) or Report Publication Announcement (RPA). Therefore, the best fitting classification is Capital/Financing Update (CAP).
2016-09-21 Chinese
关于第一大股东股份质押的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement regarding the pledge of shares by the company's largest shareholder. It details the number of shares pledged, the pledge period, the purpose of the pledge, and the shareholder's financial status. There is no financial report, earnings data, or management discussion. The document is a regulatory announcement about share pledging, which fits the category of Regulatory Filings (RNS) as it does not fall under more specific categories like Major Shareholding Notification (MRQ) since it concerns pledged shares, not ownership threshold changes, nor does it fit into capital changes or share issuance categories. The document length is short and it is an announcement rather than a report.
2016-09-02 Chinese
2016年半年度报告摘要
Interim / Quarterly Report Classification · 95% confidence The document is titled as a '2016 年半年度报告摘要' which translates to '2016 Half-Year Report Summary'. It contains detailed financial data for the first half of the year (1-6 months), including total assets, net profit, earnings per share, and shareholder information. It also includes management discussion and analysis of business performance and operational highlights for the half-year period. The document length is 3099 characters, which is relatively short but contains substantive financial data and analysis, not just an announcement or a link to a report. The content matches the characteristics of an Interim / Quarterly Report (IR), which covers a period shorter than a full fiscal year and includes actual financial statements and management commentary. Therefore, the correct classification is IR with high confidence. H1 2016
2016-08-25 Chinese
2016年半年度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "2016 年半年度报告" which translates to "2016 Semi-Annual Report." It contains detailed financial data, including income, profit, cash flow, and segment analysis for the first half of 2016. It includes sections such as company overview, financial data and indicators, board report, important matters, and governance information. The document explicitly states it is a half-year report and includes comprehensive financial statements and management discussion. It is not a brief announcement or a certification letter but a full financial report for a period shorter than a full fiscal year. Therefore, it fits the definition of an Interim / Quarterly Report (IR). H1 2016
2016-08-25 Chinese
关于子公司签订重组口蹄疫亚单位疫苗系列产品研发技术开发（合作）合同的补充公告
Regulatory Filings Classification · 95% confidence The document is a public announcement by a company regarding a supplementary notice about a contract signed by its subsidiary for the development of a vaccine product. It details the rights, fees, and payment methods related to the contract. The document is relatively short (1227 characters) and does not contain financial statements, audit information, or detailed financial results. It is not an annual or interim report, nor is it a call transcript or earnings release. It is a specific announcement about a business cooperation contract and its terms, which fits best under Regulatory Filings (RNS) as it is a general regulatory announcement that does not fit other specific categories.
2016-08-24 Chinese
关于子公司签订重组口蹄疫亚单位疫苗系列产品研发技术开发（合作）合同的公告
Regulatory Filings Classification · 95% confidence The document is an announcement by a company about a contract signed by its subsidiary for research and development cooperation on a vaccine product. It details the parties involved, contract content, cooperation terms, and potential impact on the company. There are no financial statements, no quarterly or annual report data, no earnings highlights, no voting results, no management changes, no legal proceedings, no merger or acquisition details, and no regulatory certifications. The document is relatively short (1652 characters) and serves as a formal announcement of a business cooperation agreement rather than a financial or regulatory report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous announcements that do not fit other specific categories.
2016-08-23 Chinese

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.